ESSA Pharma Inc. (EPIX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.76
-0.01 (-0.56%)
At close: Jan 15, 2025, 3:59 PM
1.76
-0.28%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 217.00 | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | 118.49K | 121.79K | 109.46K | 110.32K | n/a | 34.49K | 46.15K | 66.18K | n/a | n/a | n/a | n/a |
Gross Profit | n/a | -118.49K | -121.79K | -109.46K | -110.32K | n/a | -34.49K | -46.15K | -65.96K | n/a | n/a | n/a | n/a |
Operating Income | n/a | -32.13M | -35.34M | -36.91M | -23.12M | -12.15M | -10.80M | -11.65M | -19.64M | -9.31M | -1.82M | -1.36M | -1.94K |
Interest Income | n/a | 5.55M | 1.74M | 235.00K | 559.72K | 26.25K | 42.73K | n/a | n/a | 618.25 | 217.00 | 1.31K | 1.42 |
Pretax Income | n/a | -26.58M | -35.22M | -36.84M | -23.73M | -10.40M | -11.60M | -4.38M | -12.99M | -8.57M | -1.82M | -1.37M | -1.94K |
Net Income | n/a | -26.58M | -35.10M | -36.81M | -23.45M | -10.44M | -11.63M | -4.50M | -13.14M | -8.57M | -1.82M | -1.37M | -1.94K |
Selling & General & Admin | n/a | 10.81M | 12.54M | 12.78M | 11.37M | 5.47M | 5.93M | 5.14M | 5.64M | 3.70M | 1.04M | 371.18K | 298.27 |
Research & Development | 21.21M | 21.32M | 24.41M | 24.26M | 12.15M | 6.70M | 4.87M | 5.73M | 13.06M | 4.39M | 671.60K | 1.59M | 1.76K |
Other Expenses | n/a | n/a | 1.74M | 109.46K | 515.00K | 35.00K | -40.00K | -37.00K | 79.00K | 1.15M | n/a | n/a | n/a |
Operating Expenses | 21.21M | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.80M | 10.87M | 18.70M | 9.23M | 1.74M | 1.37M | 1.94K |
Interest Expense | n/a | 6.94K | 14.00K | 22.22K | 618.00K | 603.00K | 912.00K | 785.00K | 938.00K | 77.77K | 87.59K | n/a | n/a |
Selling & Marketing Expenses | n/a | 22.57K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.83K | 22.96 |
Cost & Expenses | n/a | 32.13M | 36.96M | 37.14M | 23.52M | 12.17M | 10.80M | 10.87M | 18.70M | 9.23M | 1.74M | 1.37M | 1.94K |
Income Tax | n/a | 1.60K | -112.00K | -34.35K | -289.00K | 38.00K | 27.00K | 116.00K | 151.00K | 77.77K | 87.59K | 0.28 | n/a |
Shares Outstanding (Basic) | 44.28M | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784.00K | 732.00 |
Shares Outstanding (Diluted) | 44.28M | 44.09M | 44.04M | 38.48M | 22.44M | 8.43M | 4.57M | 1.45M | 1.35M | 917.65K | 784.38K | 784.38K | 732.65 |
EPS (Basic) | -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
EPS (Diluted) | -0.64 | -0.6 | -0.8 | -0.96 | -1.04 | -1.24 | -2.55 | -3.09 | -9.77 | -9.34 | -2.33 | -1.75 | -2.65 |
EBITDA | n/a | -26.46M | -35.08M | -36.71M | -23.01M | -12.13M | -10.77M | -3.55M | -18.67M | -9.38M | -1.76M | -1.34M | -1.91K |
Depreciation & Amortization | n/a | 118.49K | 121.79K | 109.46K | 110.32K | 18.30K | 34.49K | 46.15K | 66.18K | 39.10K | 23.39K | 24.62K | 25.41 |